Iannazzo, Sergio, SIHS Health Economics Consulting, Turin, Italy
-
Vol 18, No 1 (2017) - Original research
Cost-effectiveness analysis of empagliflozin in the treatment of patients with type 2 diabetes and established cardiovascular disease in Italy, based on the results of the EMPA-REG OUTCOME study
Abstract HTML PDF
ISSN: 2240-256X